AKT1 and neoplasm: Since mTOR inhibition amplifies autophagy—a pro-survival mechanism [24]—we hypothesized that adding autophagy inhibitors could enhance the anti-tumorigenic effect of the PI3K/Akt/mTOR pathway inhibitors in NEN tumor cells.